BioSpace News Archive

FDA

RECORDATI RARE DISEASES: CARBAGLU® (Carglumic Acid) Tablets 200mg Receives U.S. FDA Approval for a New Indication to Treat Acute Hyperammonemia Associated with Propionic Acidemia and Methylmalonic Acidemia

CARBAGLU is First and Only FDA-Approved Medication for Hyperammonemia Associated with These Rare Conditions

January 26, 2021
·
6 min read
Biotech Beach

Qualigen Therapeutics Announces Completion of Milestone Related to the License and Technology Transfer of its FastPack® Diagnostics Products in China

Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announces achievement of a milestone event which triggered a payment obligation from Yi Xin Zhen Duan Jishu (Suzhou) Ltd. of Suzhou, China (Yi Xin) to Qualigen.

January 26, 2021
·
6 min read
Business

Elevian Adds Deep Scientific and Business Expertise

Additions include Greg Curhan as CFO, Christopher Dale, Ph.D., as head of protein manufacturing and CMC, scientific advisor Jason Kim, Ph.D., and business advisors Mark Leslie and Tony Robbins

January 26, 2021
·
4 min read
BioCapital

emocha Secures Funding from National Institutes of Health to Deploy and Test Digital Medication Adherence Platform to Transplant Recipients

emocha Health, the leading digital medication adherence platform that serves over 450 public health departments nationwide, has secured a total of $6.1M in funding from the National Institutes of Health

January 26, 2021
·
4 min read
Drug Development

Care Access Research Collaborates with AstraZeneca on Phase III Clinical Trial for COVID-19 Long-Acting Antibody Combination

Care Access Research, a decentralized research organization (DRO) that operates as one connected team of physicians and research experts, today announced a collaboration with global biopharmaceutical company AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca’s long-acting monoclonal antibody (LAAB) combination for the potential prevention of COVID-19.

January 26, 2021
·
3 min read
Biotech Bay

Novel SARS CoV-2 Saliva Collection Devices Address COVID-19 Testing Challenges, Improving Lab Efficiency and PCR Test Performance

GenTegra, LLC, a Pleasanton, California-based company, announced today a study on the development and characterization of two novel COVID-19 saliva sample collection tube devices.

January 26, 2021
·
2 min read
MediXall Group Launches Nationwide Marketing Campaign for Health Karma

MediXall Group, Inc. (OTCQB:MDXL), a healthcare technology company, announced today the kick-off of a nationwide marketing campaign for Health Karma, a consumer technology platform for health and wellness.

January 26, 2021
·
3 min read
Biotech Beach

Therapeutic Solutions International Reports Enhancement of StemVacs Immune Stimulating Activity Using Neuromodulatory Compound Homotaurine

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced filing of a patent disclosing enhancement of natural killer cell and T cell activity by StemVacs after treatment with homotaurine, a safe blood-brain barrier permeable GABA A-R-specific agonist

January 26, 2021
·
2 min read
Business

Echosens Partners with Gastrologix to Provide Independent GI Practices with FibroScan for Non-Invasive, Cost-effective Liver Health Examinations

Echosens, a high-technology company offering the FibroScan family of products, announces its partnership with Gastrologix to provide independent GI practices in its group purchasing organization (GPO) with the enhanced services of FibroScan, a non-invasive device that helps to assess liver health

January 26, 2021
·
2 min read
Business

Biorasi Welcomes Neurology Professor Dr. Ole Isacson to Scientific Advisory Board

Biorasi, a leading global full-service contract research organization (CRO), is proud to announce the appointment of Ole Isacson, MD, PhD, Professor of Neurology and Neuroscience, to the position of Scientific Advisory Board (SAB) member

January 26, 2021
·
2 min read